Anti-Met VHH Pool Overcomes MET-targeted Cancer Therapeutic Resistance

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0351
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

VHH-Photosensitizer Conjugates for Targeted Photodynamic Therapy of Met-Overexpressing Tumor Cells

Antibodies
Drug DiscoveryAllergyImmunology
2019English

Targeting C-Met Receptor Overcomes TRAIL-Resistance in Brain Tumors

PLoS ONE
Multidisciplinary
2014English

Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for Cancer Treatment

Biomedicines
BiochemistryMedicineGeneticsMolecular Biology
2015English

Activation of the Met Kinase Confers Acquired Drug Resistance in FGFR-targeted Lung Cancer Therapy

Oncogenesis
Cancer ResearchMolecular Biology
2016English

MET Targeted Therapy for Lung Cancer: Clinical Development and Future Directions

Lung Cancer: Targets and Therapy
Oncology
2012English

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology
Oncology
2011English

MET in Glioma: Signaling Pathways and Targeted Therapies

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Discovery and Therapeutic Exploitation of Mechanisms of Resistance to MET Inhibitors in Glioblastoma

Clinical Cancer Research
Cancer ResearchOncology
2018English

Activation of KRAS Mediates Resistance to Targeted Therapy in MET Ex on 14 Mutant Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy